<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-QM9V7798</identifier><date>1997</date><creator>Preželj, Janez</creator><relation>documents/doc/Q/URN_NBN_SI_doc-QM9V7798_001.pdf</relation><relation>documents/doc/Q/URN_NBN_SI_doc-QM9V7798_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 75-79</format><identifier identifier_type="COBISSID_HOST">7711193</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-QM9V7798</identifier><language>slv</language><publisher>ZENECA International</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="slv">Androgen antagonists</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="eng">Prostatic neoplasms</subject><subject language_type_id="eng">Testosterone</subject><title>Principi horomonskega zdravljenja raka prostate</title></Record>